marketcap
Facebook
Twitter
Telegram
Report an ErrorQuarterly report 2024-Q3
added 11-13-2024
Pieris Pharmaceuticals Financial Ratios 2011-2024 | PIRS
Annual Financial Ratios Pieris Pharmaceuticals
| 2023 | 2022 | 2021 | 2020 | 2019 | 2018 | 2017 | 2016 | 2015 | 2014 | 2013 | 2012 | 2011 | |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
P/E |
-0.7 | -2.7 | -5.3 | -3.7 | -7.3 | -5.3 | -19.0 | -3.9 | -4.2 | -3.9 | - | - | - |
P/S |
0.4 | 3.5 | 7.8 | 4.7 | 4.0 | 4.9 | 13.3 | 15.1 | 20.3 | 7.2 | - | - | - |
EPS |
-0.3 | -0.5 | -0.7 | -0.7 | -0.6 | -0.5 | -0.4 | -0.6 | -0.4 | -0.7 | 0.0 | - | - |
EV (Enterprise Value) |
10.7 M | 120 M | 229 M | 142 M | 213 M | 168 M | 390 M | 68.5 M | 33 M | 20.4 M | -3.69 M | - | - |
EBITDA per Share |
-0.31 | -0.55 | -0.76 | -0.582 | -0.516 | -0.57 | -0.324 | -0.537 | -0.389 | -0.00113 | - | - | - |
EV/EBITDA |
-3.6 | -2.1 | -4.7 | -2.2 | -20.9 | -2.6 | -2.3 | -3.2 | - | - | - | ||
PEG |
0.09 | -0.17 | -0.38 | 0.17 | 0.61 | 0.21 | -0.7 | 0.11 | -0.1 | 0.0 | - | - | - |
P/B |
0.6 | 3.3 | 4.8 | 4.4 | 3.6 | 3.5 | 29.1 | 3.5 | 1.9 | 2.2 | - | - | - |
P/CF |
-0.3 | -1.5 | -31.9 | -2.8 | -3.4 | -51.1 | 7.0 | -5.9 | -4.5 | -7.3 | - | - | - |
ROE % |
-91.72 | -119.15 | -90.12 | -119.99 | -49.60 | -66.99 | -153.16 | -90.38 | -45.16 | -54.70 | - | - | - |
ROA % |
-63.45 | -34.85 | -29.79 | -35.45 | -18.05 | -18.93 | -16.99 | -65.02 | -41.41 | -45.01 | - | - | - |
ROCE % |
-111.20 | -155.66 | -102.12 | -40.94 | -23.80 | -33.06 | -25.12 | -85.30 | -43.92 | -39.25 | - | - | - |
Current Ratio |
3.2 | 1.4 | 1.5 | 3.4 | 4.3 | 2.8 | 2.0 | 3.9 | 11.3 | 5.6 | - | - | - |
DSO |
27.2 | 64.3 | 29.2 | 21.2 | 53.5 | 33.9 | 224.5 | 3.6 | - | 1.0 | - | - | - |
DIO |
- | - | - | - | - | - | - | - | - | - | - | - | - |
DPO |
- | - | - | - | - | - | - | - | - | - | - | - | - |
Operating Cycle |
27.2 | 64.3 | 29.1 | - | - | - | - | - | - | - | - | - | - |
Cash Conversion Cycle |
27.2 | 64.3 | 29.1 | - | - | - | - | - | - | - | - | - | - |
All numbers in USD currency
Quarterly Financial Ratios Pieris Pharmaceuticals
| 2024-Q3 | 2024-Q2 | 2024-Q1 | 2023-Q4 | 2023-Q3 | 2023-Q2 | 2023-Q1 | 2022-Q4 | 2022-Q3 | 2022-Q2 | 2022-Q1 | 2021-Q4 | 2021-Q3 | 2021-Q2 | 2021-Q1 | 2020-Q4 | 2020-Q3 | 2020-Q2 | 2020-Q1 | 2019-Q4 | 2019-Q3 | 2019-Q2 | 2019-Q1 | 2018-Q4 | 2018-Q3 | 2018-Q2 | 2018-Q1 | 2017-Q4 | 2017-Q3 | 2017-Q2 | 2017-Q1 | 2016-Q4 | 2016-Q3 | 2016-Q2 | 2016-Q1 | 2015-Q4 | 2015-Q3 | 2015-Q2 | 2015-Q1 | 2014-Q4 | 2014-Q3 | 2014-Q2 | 2014-Q1 | 2013-Q4 | 2013-Q3 | 2013-Q2 | 2013-Q1 | 2012-Q4 | 2012-Q3 | 2012-Q2 | 2012-Q1 | 2011-Q4 | 2011-Q3 | 2011-Q2 | 2011-Q1 | |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
EPS |
-2.19 | -2.76 | -3.95 | - | -8.7 | 3.63 | -14.15 | - | -0.13 | -0.14 | -0.07 | - | -0.24 | -0.25 | -0.07 | - | -0.26 | -0.09 | -0.07 | - | -0.05 | -0.24 | -0.2 | - | -0.11 | - | -0.17 | - | -0.16 | -0.23 | -0.19 | - | -0.14 | -0.14 | -0.1 | - | -0.1 | -0.12 | -0.13 | - | -0.17 | -0.24 | - | - | - | - | - | - | - | - | - | - | - | - | - |
EBITDA per Share |
- | - | -4.31 | - | - | - | -16 | - | -0.13 | -0.17 | -0.1 | - | -0.25 | -0.27 | -0.09 | - | -0.24 | -0.09 | -0.06 | - | -0.05 | -0.24 | -0.21 | - | -0.14 | -0.04 | -0.16 | - | -0.11 | -0.18 | -0.18 | - | -0.14 | -0.14 | -0.11 | - | -0.09 | -0.11 | -0.12 | - | -0.25 | -0.22 | 0.02 | - | - | - | - | - | - | - | - | - | - | - | - |
ROE % |
-94.45 | -111.95 | -82.94 | -110.71 | -137.93 | -129.91 | -149.27 | -46.31 | -77.01 | -70.96 | -104.13 | -74.79 | -120.82 | -136.15 | -118.93 | -73.58 | -78.63 | -37.64 | -44.59 | -48.10 | -63.50 | -73.86 | -51.47 | -37.74 | -99.00 | -144.86 | -231.88 | -218.17 | -242.74 | -206.03 | -141.83 | -64.38 | -76.98 | -65.02 | -53.04 | -35.84 | -47.07 | -45.70 | -50.37 | -27.31 | -27.69 | -138.38 | -290.80 | -290.73 | -290.35 | -168.43 | - | - | - | - | - | - | - | - | - |
ROA % |
-63.09 | -67.13 | -48.26 | -13.57 | -23.38 | -15.09 | -23.36 | -17.26 | -27.33 | -23.86 | -33.86 | -23.67 | -37.27 | -40.80 | -35.52 | -21.74 | -23.58 | -11.81 | -15.43 | -17.50 | -21.86 | -24.37 | -16.18 | -10.66 | -17.46 | -19.90 | -29.47 | -24.20 | -41.87 | -52.75 | -59.82 | -46.32 | -57.87 | -51.75 | -45.37 | -32.86 | -42.10 | -39.79 | -42.56 | -22.47 | -22.50 | -124.07 | -8955.35 | -8955.28 | -8955.25 | -8844.44 | - | - | - | - | - | - | - | - | - |
ROCE % |
-104.44 | -123.87 | -96.45 | -133.95 | -167.97 | -163.29 | -182.33 | -61.92 | -97.23 | -84.56 | -120.43 | -84.41 | -126.30 | -132.90 | -112.03 | -69.33 | -75.00 | -38.78 | -47.59 | -50.29 | -69.84 | -83.70 | -65.50 | -45.53 | -90.52 | -115.97 | -178.84 | -182.96 | -207.45 | -186.95 | -141.44 | -64.83 | -77.29 | -65.27 | -53.65 | -35.71 | -45.93 | -43.69 | -47.72 | -25.68 | -26.06 | -137.76 | -290.80 | -290.73 | -290.35 | -168.43 | - | - | - | - | - | - | - | - | - |
Current Ratio |
- | - | - | - | 2.1 | 1.9 | - | 1.4 | 1.6 | - | 1.6 | 1.5 | 1.5 | 1.4 | 1.5 | 1.4 | 1.4 | 1.4 | 1.4 | 1.6 | 1.6 | 1.6 | 1.6 | 1.4 | 1.4 | 1.4 | 1.4 | 1.1 | 1.1 | 1.1 | 1.1 | 3.6 | 3.6 | 3.6 | 3.6 | 12.0 | 12.0 | 12.0 | 12.0 | 5.7 | 5.6 | 5.6 | 5.6 | 1.1 | 11.0 | 0.0 | - | - | - | - | - | - | - | - | - |
DSO |
- | - | 2078.1 | - | 4.7 | - | - | - | 7.0 | 20.3 | 20.6 | - | 106.3 | 258.5 | 51.1 | - | 53.0 | 13.8 | 29.2 | - | 40.9 | 116.2 | 50.7 | - | 29.5 | 21.1 | 200.5 | - | 361.2 | 765.5 | 530.1 | - | 6.7 | 4.9 | 2.1 | - | 1.9 | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - |
DIO |
- | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - |
DPO |
- | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - |
Operating Cycle |
- | - | 2078.1 | - | 4.7 | - | - | - | 7.0 | 20.3 | 20.6 | - | 106.3 | 258.5 | 51.1 | - | 53.0 | 13.8 | 29.2 | - | 40.9 | 116.2 | 50.7 | - | 29.5 | 21.1 | 200.5 | - | 361.2 | 765.5 | 530.1 | - | 6.7 | 4.9 | 2.1 | - | 1.9 | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - |
Cash Conversion Cycle |
- | - | 2078.1 | - | 4.7 | - | - | - | 7.0 | 20.3 | 20.6 | - | 106.3 | 258.5 | 51.1 | - | 53.0 | 13.8 | 29.2 | - | 40.9 | 116.2 | 50.7 | - | 29.5 | 21.1 | 200.5 | - | 361.2 | 765.5 | 530.1 | - | 6.7 | 4.9 | 2.1 | - | 1.9 | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - |
All numbers in USD currency